Osteo-Pharma and Emultech Announce Joint Venture to Develop First-in-Class Disease-Modifying Treatment for Osteoarthritis

Nov 17, 2021


Bone-Tech logo

Bone-Tech logo

AMSTERDAM - November 17, 2021 - (Newswire.com)

Emultech and Osteo-Pharma today announced a joint venture, Bone-Tech, to develop what could be the first disease-modifying treatment for osteoarthritis of the knee. Bone-Tech brings together Osteo-Pharma's novel combination drug therapy for the local treatment of osteoarthritis with Emultech's world-leading microfluidics' microspheres technology.  Bone-Tech's patented OsteoActivator™ microspheres treatment promises to be the first and only extended-release treatment targeting subchondral bone remodelling for patients suffering from osteoarthritis-related pain and disability.

Osteoarthritis (OA), the most common form of arthritis, is a chronic, degenerative disease affecting over 1.5 billion people globally. OA causes life-long pain and is a leading cause of disability in the US and worldwide, accounting for >$185 billion in annual costs in the US alone in 2016. In OA patients, subchondral bone is characterized by impaired bone remodelling and the presence of bone marrow lesions (BML). BML's are a hallmark in OA diagnosis and are strongly associated with pain, are a prognostic marker for cartilage loss and are predictive for the need for knee replacement surgery.

"Intraosseous injection of OsteoActivator™ microspheres directly into subchondral bone locally targets osteoblast and osteoclast cells to restore bone remodelling, improves bone quality and relieves pain. There are currently no disease modifying treatments in the OA therapies market, and as such, OsteoActivator™ microspheres will be the first of its kind", said Jan Gossen, CEO of Osteo-Pharma.

"With its extended-release microsphere formulation, we believe the Bone-Tech product holds the potential to disrupt the current treatment paradigm, and we are dedicated to bringing this important new therapy to market for the millions of patients confronting this relentless disease", said Rene Hansen, CEO of Emultech.

Bone-Tech's novel approach has demonstrated proof-of-concept in in-vitro and animal studies and is under development in preparation for IND filing and first-in-man studies. The Bone-Tech product employs proprietary microsphere technology for the extended-release of a combination of two well-known therapeutic agents delivered via intraosseous injection. Bone-Tech plans to pursue a rapid and low risk 505(b)(2) strategy to progress the product through clinical trials.   

Bone-Tech is actively seeking venture and/or strategic partners to support clinical development. If interested, please contact Bone-Tech using the contact information below. 

About Osteo-Pharma

Osteo-Pharma is a Life Sciences company developing novel medical devices and pharmaceuticals to improve the local healing of bone defects and fractures. Its proprietary OsteoActivator platform is currently used to develop products for both dental and orthopedic applications. The company has recently announced its MREC approval for the initiation of a clinical trial for their lead product, OsteoActivator-P, in patients.

About Emultech

Emultech has developed the first and only continuous production of microparticles based on microfluidics. Emultech's system enables superior control of particle properties (monodispersity, size, circularity and morphology) with high encapsulation efficiency, resulting in improved and adjustable loading, controlled drug release and degradation profiles with easier injectability. Our process is low energy and safe for all molecules, and parallelization enables instant, low risk, scale-up for high throughput production that is suitable for GMP. 

Press Contact: 

Scott Fleming, CCO, Emultech BV   [email protected]   +31 6 46 87 69 89

Other Contact:

Jan Gossen, CEO, Osteo-Pharma BV  [email protected] 




Press Release Service by Newswire.com

Original Source: Osteo-Pharma and Emultech Announce Joint Venture to Develop First-in-Class Disease-Modifying Treatment for Osteoarthritis

More News

Putting skin recovery at the heart of beauty care

Oct 30, 2026

Putting skin recovery at the heart of beauty care

Skin recovery took center stage at a gathering of dermatologists, cosmetic surgeons and aesthetic practitioners in Taguig City, where a discussion on barrier care connected skincare science with the experiences and professional interests of the medical community. Held on October 21 at the Intramuros Tent of Manila House Private Club in Bonifacio Global City, the roundtable discussion brought together the Pan Pacific Aesthetic Institute Foundation, Lamelex, Golden Visa Central and Manila House. Their collaboration provided a setting for scientific learning, professional exchange and conversations about opportunities beyond clinical practice. For the beauty discussion, the emphasis was on caring for the skin barrier, particularly after dermatologic and aesthetic procedures. Dr. Finesse Angelica Evangelista addressed this in her presentation, “The Science of Recovery: Optimizing Barrier Repair in Post-Procedure and Compromised Skin.” Her discussion underscored the importance of skin barrier integrity in supporting recovery. It also placed barrier-focused care within a professional conversation about the needs of skin following procedures or when its condition is compromised. That focus is central to Lamelex’s approach. The brand presented its multi-lamellar vesicle technology, a skincare delivery approach designed to support the skin’s natural barrier structure and in­gre­­­­d­ient delivery. Its professional skincare offe­rings combine formulations and protocols intended for barrier-focused care. The technology formed part of the brand’s showcase, which included professional skincare products, testers, merchandising and educational materials. These gave participants opportunities to explore its approach to skin barrier care alongside the scientific discussion. Medical professionals also received product kits for further exploration and evaluation in their respective practices. Catherine Andres-Gamo, chief exe­cutive officer of Pretty Skin Lamelin Philippines, expanded the conversation from products to advocacy. Sha­ring Lamelex’s commitment to scientific education, skincare innovation and collaboration with the medical community, she encouraged participants to become skin barrier advocates. Her message called for greater awareness of barrier-first skincare in clinical practice, linking the brand’s educational efforts with the professionals who assess and care for patients’ skin. The evening brought that advocacy into direct conversation with dermatologists, cosmetic surgeons and other aesthetic practitioners. The foundation, meanwhile, provided a platform for professional exchange within the aesthetic medical community. Manila House hosted the gathering, bringing professionals from different fields into a shared setting for learning and relationship building. Alongside the skincare discussions, Golden Visa Central founder and president Vicky Luis introduced international investment opportunities and wealth diversification. Her presentation offered participants perspectives on long-term financial planning beyond their clinical work, extending the evening’s scope to their broader professional and personal interests. The gathering linked these different areas through partnerships among the foundation’s leadership, Golden Visa Central, Manila House and the Lamelex team. Each contributed expertise to a forum that combined clinical interests with opportunities for professional growth. For Lamelex, the continuing direction is to build its community of skin barrier advocates through scientific education and continued collaboration with medical professionals. The roundtable provided one setting for that exchange, bringing its products, technology and barrier-care message to practitioners who could explore and evaluate them for use in their respective practices.

Jewelry for every side of a woman

Oct 30, 2026

Jewelry for every side of a woman

Jewelry passed from mother to daughter carries more than gemstones and gold. For designer Kristine Dee, it also holds the stories behind each piece, including her mother’s purchase to celebrate a hard-earned business deal. Those personal connections inspire “Modern Heirloom,” one of three chapters in “The Woman Within,” her collection exploring the different sides of a woman through fine jewelry. Its three chapters, “Modern Heirloom,” “Quiet Strength” and “Playful Femininity,” move from sentiment to assurance to joy. Each reflects a side of a woman that Dee has observed in her clients and herself. “They try out other styles which are not their usual, and the choice follows their emotions, what they felt at that time, how that particular jewelry piece made them feel when worn. Each capsule collection shows the different versions we, as women, find ourselves in.” For “Modern Heirloom,” Dee draws on her mother Elizabeth’s practice of passing jewelry to her daughters, along with the memories behind it. Among them is a piece Elizabeth bought after closing a business deal she had worked hard to secure. “It is not just the piece that she shared, but the story that comes with them,” Dee says. That sense of continuity takes shape in classic gemstones and versatile designs. Multicolored sapphire and diamond necklaces hang from substantial gold-ball chains. A pearl necklace features diamonds and a detachable kunzite centerpiece, allowing the wearer to move between dressier and more casual looks. “Quiet Strength” turns toward architecture, emphasizing line, proportion and structure. Smooth gold surfaces, curves and carefully placed diamonds give rings and cuffs their presence. Dee’s background in industrial design informs this attention to form and how a piece sits on the body. “Each millimeter matters,” she says. A softer mood emerges in “Playful Femininity.” Mint tourmaline, pink spinel and diamonds appear in linked elements that sway with the wearer, while a coordinating ring allows for stacking. Elsewhere, a hand-carved mother-of-pearl ribbon flows into waves of rubies and diamonds. Across the collection, gemstones are set in 14-karat and 18-karat white, yellow and rose gold. Many designs bear the names of loyal clients, relatives and friends, extending the personal connections behind the jewelry. For Dee, their place is in everyday wardrobes. Statement necklaces can accompany a tank top and jeans or a dress, while rings and cuffs can be layered to suit the day. “The best way to style fine jewelry for a woman is based on her lifestyle and personality, so she can reach for them day after day, comfortably and confidently, and wear them in more ways than one.” The collection is available at the Kristine Dee showroom in BGC, Taguig City, with resizing and customization offered. A Power Plant Mall pop-up runs from Nov. 7 to Jan. 28, 2027, bringing the collection’s expressions of memory, strength and joy into women’s daily choices.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.